SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies is trending due to a strategic partnership with Crypto.com to launch an exclusive U.S. prediction markets platform, coupled with plans for sports betting expansion. The community is actively discussing the stock's significant surge, high volume, and potential for a short squeeze given its low float. However, some are also debating the possibility of future share offerings amidst the intense market activity.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor is trending sharply following a stellar earnings report that surpassed expectations with strong margins and aggressive capital expenditure plans, driven by persistent AI chip demand. The community is actively discussing the CEO's "AI megatrend" outlook, interpreting the results as a significant bullish indicator for the entire semiconductor sector. This strong performance is expected to generate positive momentum for related companies in the AI supply chain.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial (RILY) is experiencing an intense surge of conversation following its Q3 financial report release, which arrived significantly ahead of its NASDAQ compliance deadline and indicated a strong return to profitability. The news has ignited fervent discussions among traders, who are anticipating a major short and gamma squeeze due to high short interest and renewed confidence as delisting fears subside. The community is actively debating the potential for a substantial upward movement, with many drawing parallels to historical market squeezes like CVNA or GME.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently a focal point for investors, navigating ongoing Wall Street downgrades alongside intense discussion around a potential credit card interest rate cap and its implications for the company's Buy Now Pay Later services. Despite significant community frustration regarding recent stock performance and calls for leadership changes, many perceive PYPL as fundamentally undervalued, citing robust financials and strategic AI partnerships. This creates a deeply divided sentiment, with some confidently calling a bottom while others anticipate further price erosion amid concerns of market manipulation.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending amidst reports that Sanofi is preparing an improved takeover bid after its initial offer was rejected, sparking community discussions about a potential bidding war. This acquisition interest coincides with high anticipation for the upcoming SOL-1 Phase 3 trial data for AXPAXLI, expected in Q1 2026, which many believe could significantly re-rate the company. Investors are closely watching, noting institutional accumulation and the potential for the long-acting wet AMD therapy to reshape the market.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Advanced Micro Devices is trending due to a strategic collaboration with Tata Consultancy Services aimed at accelerating enterprise AI adoption, alongside a significant analyst upgrade. The community is actively discussing strong hyperscaler demand that reportedly has AMD's server CPUs largely sold out through 2026, with high anticipation for its MI300 series AI accelerators. This underscores AMD's growing leadership and momentum in the high-performance computing and artificial intelligence sector.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

SOXL is trending sharply higher, propelled by robust sentiment across the semiconductor industry amid encouraging economic data and positive earnings reports from key players like TSMC. The community is actively debating its substantial rally, with many anticipating continued upside driven by insatiable AI demand, while others signal caution about an "AI bubble" and potential for profit-taking given its leveraged nature. Upcoming tech conferences, such as CES, further highlight the sector's pivotal role in technological advancements.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is experiencing a surge due to intensified geopolitical focus on Greenland's vast critical mineral resources, highlighted by the formation of a U.S., Denmark, and Greenland working group on security and resource development. Community discussion is buzzing with expectations of significant U.S. investment and supply chain security, fueling heavy trading volume and speculation about a potential short squeeze for the company. This dynamic positions CRML as a central player in the global race for essential rare earth elements.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is experiencing significant investor interest driven by a surge in European defense spending, leading to substantial new orders for its MTU engines in military vehicles. The company is also gaining traction for its Small Modular Reactor (SMR) technology, which the community views as a transformative future revenue stream for energy and AI data centers. Bolstered by strong civil aerospace orders and recent analyst upgrades, investors are keenly anticipating continued growth and shareholder returns.

BlackRock Institutional Trust Company N.A. - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF ($SOXX) is trending amidst continued strong bullish sentiment, with many investors calling it an 'unbreakable' investment and actively advocating to 'buy the dip.' While some debate whether the sector's rapid ascent and new all-time highs signal an "AI bubble," the prevailing community perspective emphasizes its foundational role in future technology.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Consensus Rating of "Moderate Buy" from Brokerages

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) has earned an average recommendation of "Moderate Buy" from the seven brokerages that are covering the company, MarketBeat.com reports...

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Given Consensus Recommendation of "Moderate Buy" by Brokerages

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven ratings firms that are currently covering the firm, Marketbeat...

DiaMedica Therapeutics (NASDAQ:DMAC) Trading Up 7.4% - Here's Why

DiaMedica Therapeutics (NASDAQ:DMAC) Shares Up 7.4% - Here's Why...

DiaMedica Therapeutics (NASDAQ:DMAC) Sets New 1-Year High - Time to Buy?

DiaMedica Therapeutics (NASDAQ:DMAC) Hits New 1-Year High - Here's What Happened...

Jan Stahlberg Buys 128,426 Shares of DiaMedica Therapeutics (NASDAQ:DMAC) Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg acquired 128,426 shares of the business's stock in a transaction that occurred on Thursday, November 20th...

Insider Buying: DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Purchases 128,426 Shares of Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg acquired 128,426 shares of DiaMedica Therapeutics stock in a transaction dated Thursday, November 20th...

DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Acquires $1,234,453.50 in Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg bought 182,882 shares of the company's stock in a transaction that occurred on Tuesday, November 18th. The...

DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Acquires $1,221,802.36 in Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg bought 187,393 shares of the firm's stock in a transaction that occurred on Monday, November 17th. The...

Jan Stahlberg Acquires 208,872 Shares of DiaMedica Therapeutics (NASDAQ:DMAC) Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg bought 208,872 shares of the business's stock in a transaction dated Friday, November 21st. The stock was...

Jan Stahlberg Acquires 240,352 Shares of DiaMedica Therapeutics (NASDAQ:DMAC) Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg bought 240,352 shares of the firm's stock in a transaction on Wednesday, November 19th. The stock was...

DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.

DiaMedica Therapeutics Inc

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Current Price	$8.60
Prev Close	$8.25
Open	$8.24
Dividend Yield	0.00%
50-Day Moving Average	$7.92
Beta	1.17
Avg. Volume	441,778.00
PE Ratio	-11.99

52-Week High	$10.42
52-Week Low	$3.19
Market Capitalization	$429.64M
EPS (Annual)	-$0.605
Price to Book	8.68
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

DMAC
DiaMedica Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DMAC News

DMACDiaMedica Therapeutics Inc